www.biotronik.com
www.biotronik.com
...for atrial arrhythmia and related stroke.
COMPArative Follow-up Schedule with Home Monitoring – New results
Clinical trial of safety and effectiveness of BIOTRONIK Home Monitoring® in pacemaker patients.
BIOTRONIK Home Monitoring® reduces hospitalizations for atrial arrhythmia and related stroke in pacemaker patients
COMPAS demonstrated a 66% reduction in hospitalizations for atrial arrhythmia and related stroke in the Home Monitoring group.
COMPAS showed comparable safety event rates in both groups.
BIOTRONIK Home Monitoring® significantly reduces follow-up burden and simultaneously increases clinical actionability
COMPAS demonstrated that BIOTRONIK Home Monitoring® reduced the number of interim in-office follow-ups by 56 % …
...while at the same time making these follow-ups more often clinically actionable1
BIOTRONIK Home Monitoring® enables significantly earlier physician intervention
COMPAS demonstrated a time gain of 122 days for medical intervention through early detection of clinically relevant events.
COMPAS – The first large-scale long-term clinical trial of pacemaker patients with daily remote monitoring
COMPAS has demonstrated the safety and effectiveness of BIOTRONIK Home Monitoring® for pacemaker patients compared with conventional in-clinic care
BIOTRONIK Home Monitoring® is the first & only remote monitoring system with FDA & CE approval for safe reduction of in-office follow-ups and early detection of clinically relevant events.
* BIOTRONIK Home Monitoring® is the first and only FDA & CE approved remote monitoring system to safely reduce in-office follow-ups and to provide early detection of clinically relevant events.
1 i.e. resulting in pacemaker reprogramming or medication changes
Please fill out the contact form with your request for additional information, and you will receive an answer within 24 hours.
